Valuation: Pharmedic Pharmaceutical Medicinal

Market Cap 1,166B 44.9M 38.89M 36.78M 33.29M 62.49M 4.31B 62.96M 439M 169M 2.18B 169M 165M 6.96B P/E 2024
16.6x
P/E 2025 25.7x
Enterprise Value 1,125B 43.32M 37.53M 35.49M 32.13M 60.3M 4.16B 60.75M 423M 163M 2.11B 163M 159M 6.72B EV / Sales 2024
1.54x
EV / Sales 2025 2.75x
Free-Float
27.43%
Yield 2024
2.31%
Yield 2025 -
07-23 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-22 Tasco Pharmaceutical And Biological Company Limited acquired 11.60% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
05-07 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
01-22 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
21/10/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/10/25 PVI Infrastructure Investment Fund managed by PVI Fund Management Joint Stock Company acquired 21.64% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
25/08/25 Vu Hoang Viet acquired 5.03% stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company. CI
21/07/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
18/04/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
20/01/25 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2024 CI
18/10/24 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
17/07/24 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
22/04/24 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day+4.08%
1 week+4.08%
Current month+6.84%
1 month-3.92%
3 months-1.65%
6 months-12.04%
Current year-24.39%
1 week 110,300
Extreme 110300
124,900
1 month 109,000
Extreme 109000
126,800
Current year 109,000
Extreme 109000
185,500
1 year 102,700
Extreme 102700
189,000
3 years 73,600
Extreme 73600
189,000
5 years 59,000
Extreme 59000
189,000
10 years 36,100
Extreme 36100
189,000
Manager TitleAgeSince
Chief Executive Officer 69 16/08/2012
Chief Tech/Sci/R&D Officer 56 -
Corporate Officer/Principal 64 01/08/2019
Director TitleAgeSince
Director/Board Member 69 29/04/2014
Director/Board Member 64 20/04/2019
Director/Board Member 64 29/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
+4.08%+4.08%+20.79%+48.69% 43.1M
-0.19%+1.09%+51.85%+97.36% 1,015B
+0.33%-0.71%+50.62%+65.50% 642B
+0.49%+5.73%+20.88%+72.92% 463B
-0.22%+1.98%+36.33%+38.93% 353B
-0.07%-9.26%+15.16%+24.78% 265B
-0.31%+0.61%+2.73%+12.04% 254B
-1.53%-4.46%+36.90%+44.08% 206B
-1.60%-7.71%-20.79%-59.60% 191B
+0.49%-0.23%+30.00%+93.34% 182B
Average +0.10%-2.43%+24.45%+43.80% 357.03B
Weighted average by Cap. -0.22%-2.21%+33.99%+59.53%

Financials

2024 2025
Net sales 498B 19.19M 16.62M 15.72M 14.23M 26.71M 1.84B 26.91M 188M 72.16M 933M 72.08M 70.48M 2.98B 547B 21.05M 18.24M 17.24M 15.61M 29.3M 2.02B 29.52M 206M 79.17M 1.02B 79.08M 77.33M 3.27B
Net income 80.13B 3.09M 2.67M 2.53M 2.29M 4.3M 296M 4.33M 30.17M 11.61M 150M 11.59M 11.34M 479M 82.3B 3.17M 2.75M 2.6M 2.35M 4.41M 304M 4.45M 30.99M 11.92M 154M 11.91M 11.64M 492M
Net Debt -201B -7.75M -6.71M -6.34M -5.74M -10.78M -743M -10.86M -75.71M -29.13M -377M -29.09M -28.45M -1.2B -40.88B -1.57M -1.36M -1.29M -1.17M -2.19M -151M -2.21M -15.39M -5.92M -76.6M -5.92M -5.78M -244M
Logo Pharmedic Pharmaceutical Medicinal
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
Employees
494
Date Price Change Volume
15/09/26 124,900.00 +4.08% 1,700
09/09/26 ₫120,000.00 0.00% 1,211
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!